Mendus AB (publ) Overview
Get informed when a big investor buys or sells
+ Follow54.22
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
Mendus AB (publ)'s peg ratio stands at 54.22. That is above the Healthcare sector average of 27.75. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Mendus AB (publ) sits higher the Healthcare benchmark (27.75) with a PEG ratio of 54.22. That is roughly 95.4% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
Whether 54.22 is attractive depends on Mendus AB (publ)'s earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.
The history chart shows how Mendus AB (publ)'s PEG ratio evolved across reporting periods, while the comparison chart places IMMU.ST next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
Yes — within Healthcare, PEG ratio is commonly used to spot outliers. Mendus AB (publ)'s reading of 54.22 (sector avg 27.75) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.
